MECHANISM OF SERINE/THREONINE KINASE SURVIVAL PROMOTION
MECHANISM OF SERINE/THREONINE KINASE SURVIVAL PROMOTION
批准号:
6339716
负责人:
Nissim Hay
金额:
$2.33万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-09-01 至 2003-07-31
中文摘要
血清和某些生长因子促进存活和抑制细胞凋亡,
但实现这一目标的机制尚不清楚。已激活的表单
RAS、RAF和Src正在转型,但不能提供生存
在血清停用时发出信号,而抑制PI3激酶
促细胞凋亡与S/T蛋白激酶AKT的活化形式
PI3K下游效应分子阻断细胞凋亡。Akt的能力
促进存活依赖于其激酶活性。PI3K和Akt
似乎是传递生存信号的途径的组成部分
这最终会阻止Ced3/ICE的蛋白酶活性。这项建议
重点描述Akt促进生存的机制(S)
集中在三个方面。(1)Akt是否传递了生存信号
通过使4E-BP1失活,蛋白质翻译的抑制因子?(2)
AKT在Bcl2家族水平上干预细胞调亡
成员,线粒体的完整性、caspase活性还是Ced-4/APAF-1?
(3)Akt是否通过增加细胞间黏附和/或
抑制GSK3?细胞内b-连环蛋白的水平?
英文摘要
Serum and certain growth factors promote survival and inhibit apoptosis,
but the mechanism by which this is achieved is unclear. Activated forms
of Ras, Raf and Src are transforming but do not deliver a survival
signal upon serum withdrawal, whereas inhibition of PI3kinase
accelerated apoptosis and an activated form of the S/T kinase Akt, a
downstream effector of PI3K, blocked apoptosis. The ability of Akt to
promote survival was dependent upon its kinase activity. PI3K and Akt
appear to be components of a pathway that transduces a survival signal
that ultimately blocks Ced3/ICE protease activity. This proposal
focusses on delineating the mechanism(s) by which Akt promotes survival
concentrating on three aspects. (1) Does Akt deliver a survival signal
by inactivating 4E-BP1, the repressor of protein translation? (2) Does
Akt intervene in the apoptosis cascade at the level of Bcl-2 family
members, integrity of mitochondria, caspase activity or Ced-4/Apaf-1?
(3) Does Akt promote survival by increasing cell-cell adhesion and/or
intracellular levels of b-catenin via inhibition of GSK3?
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hexokinase 2 and cancer therapy
-
批准号:10437024
-
项目类别:
-
资助金额:$56.25万
-
财政年份:2021
-
负责人:Nissim Hay
-
依托单位:
Hexokinase 2 and cancer therapy
-
批准号:10299101
-
项目类别:
-
资助金额:$49.05万
-
财政年份:2021
-
负责人:Nissim Hay
-
依托单位:
Hexokinase 2 and cancer therapy
-
批准号:10661677
-
项目类别:
-
资助金额:$56.25万
-
财政年份:2021
-
负责人:Nissim Hay
-
依托单位:
The role of AMPK and CD36 in breast cancer tumorigenesis and metastasis
-
批准号:10377328
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:Nissim Hay
-
依托单位:
The role of AMPK and CD36 in breast cancer tumorigenesis and metastasis
-
批准号:10618782
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:Nissim Hay
-
依托单位:
Research Career Scientist Award
-
批准号:9763758
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Nissim Hay
-
依托单位:
Research Career Scientist Award
-
批准号:10454208
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Nissim Hay
-
依托单位:
Research Career Scientist Award
-
批准号:10618282
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Nissim Hay
-
依托单位:
Research Career Scientist Award
-
批准号:9911969
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Nissim Hay
-
依托单位:
Research Career Scientist Award
-
批准号:10265395
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Nissim Hay
-
依托单位:
Hexokinase 2 in liver cancer
-
批准号:9195585
-
项目类别:
-
资助金额:$39.82万
-
财政年份:2016
-
负责人:Nissim Hay
-
依托单位:
Hexokinase 2 and cancer therapy
-
批准号:8696773
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Nissim Hay
-
依托单位:
Hexokinase 2 and cancer therapy
-
批准号:8512527
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Nissim Hay
-
依托单位:
Hexokinase 2 and cancer therapy
-
批准号:8330561
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Nissim Hay
-
依托单位:
Hexokinase 2 and cancer therapy
-
批准号:10171394
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Nissim Hay
-
依托单位:
Akt, cellular senescence, and lifespan
-
批准号:7394933
-
项目类别:
-
资助金额:$29.71万
-
财政年份:2006
-
负责人:Nissim Hay
-
依托单位:
Akt, cellular senescence, and lifespan
-
批准号:7223511
-
项目类别:
-
资助金额:$30.32万
-
财政年份:2006
-
负责人:Nissim Hay
-
依托单位:
Akt, cellular senescence, and lifespan
-
批准号:7584082
-
项目类别:
-
资助金额:$29.71万
-
财政年份:2006
-
负责人:Nissim Hay
-
依托单位:
Akt, cellular senescence, and lifespan
-
批准号:7033151
-
项目类别:
-
资助金额:$31.23万
-
财政年份:2006
-
负责人:Nissim Hay
-
依托单位:
Akt, cellular senescence, and lifespan
-
批准号:7795180
-
项目类别:
-
资助金额:$29.42万
-
财政年份:2006
-
负责人:Nissim Hay
-
依托单位:
海外基金